Redefining microbiome-based therapeutics

MRM Health's proprietary technology platform brings live microbial therapeutics development to the next level by combining rationally selected strains into synergistic consortia through a proprietary optimization process.

About MRM Health

MRM Health NV, Ghent, Belgium, is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.

Microbiome experts

MRM Health is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research.

Corporate Video

Strong industrial and financial support

MRM Health has a corporate collaboration with DuPont Nutrition Biosciences in the discovery and development of microbiome-based therapeutics in the field of metabolic diseases. Other therapeutic areas are available for partnering. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB.

Our discovery engine

MRM Health combines a number of proprietary innovative technologies as its discovery engine. This includes direct access to the most advanced simulator of the human gut, the Simulator of the Human Intestinal Microbial Ecosystem (SHIME®). In addition, through strategic partnerships with international research centers, MRM Health has secured extensive complementary microbiome and bioinformatics capabilities and taps into a multidisciplinary knowhow in inflammatory diseases and patient insights.

Partnership with VIB, KU Leuven and UGent

VIB is an excellence-based entrepreneurial research institute in life sciences that focuses on translating basic scientific results into pharmaceutical, agricultural and industrial applications. VIB works in close partnership with Flemish universities, including KU Leuven and Ghent University.

In the news

MRM Health announced a financing of more than €14m from prestigious private equity funds and institutions as well as an industry collaboration with DuPont Nutrition & Biosciences in the field of metabolic diseases

Read more